Close

Sanofi's (SNY) Soliqua 100/33 Approved by FDA as T2D Treatment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. BA
7. HCP
8. SNAP
9. TMUS
10. MSFT


Go back to Sanofi's (SNY) Soliqua 100/33 Approved by FDA as T2D Treatment
SANOFI (NASDAQ: SNY) Delayed: 49.36 +2.75 (5.90%)
Previous Close $46.61    52 Week High $44.76 
Open $48.80    52 Week Low $36.81 
Day High $49.83    P/E N/A 
Day Low $48.65    EPS $0.00 
Volume 6,469,463